12.54% | % of shares held by all insiders |
84.33% | % of shares held by institutions |
96.43% | % of float held by institutions |
192 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Paradigm Biocapital Advisors LP | 2,389,902 | 30 Mar 2024 | 9.67% | 111,417,228 |
Atlas Venture Life Science Advisors, LLC | 2,287,233 | 30 Mar 2024 | 9.25% | 106,630,800 |
Orbimed Advisors LLC. | 1,702,237 | 30 Mar 2024 | 6.89% | 79,358,287 |
Bain Capital Life Sciences Investors, LLC | 1,317,213 | 30 Mar 2024 | 5.33% | 61,408,468 |
State Street Corporation | 1,091,211 | 30 Mar 2024 | 4.41% | 50,872,255 |
Price (T.Rowe) Associates Inc | 944,213 | 30 Mar 2024 | 3.82% | 44,019,209 |
Perceptive Advisors Llc | 939,866 | 30 Mar 2024 | 3.80% | 43,816,551 |
Blackrock Inc. | 901,595 | 30 Mar 2024 | 3.65% | 42,032,357 |
Frazier Life Sciences Management, L.P. | 785,000 | 30 Mar 2024 | 3.18% | 36,596,699 |
Vanguard Group Inc | 782,751 | 30 Mar 2024 | 3.17% | 36,491,850 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 828,618 | 30 May 2024 | 3.35% | 38,630,170 |
Vanguard Total Stock Market Index Fund | 455,540 | 30 Mar 2024 | 1.84% | 21,237,274 |
Price (T.Rowe) New Horizons Fund | 453,611 | 30 Mar 2024 | 1.83% | 21,147,344 |
Fidelity Select Portfolios - Biotechnology | 393,679 | 29 Apr 2024 | 1.59% | 18,353,314 |
iShares Russell 2000 ETF | 222,964 | 30 May 2024 | 0.90% | 10,394,581 |
Vanguard Extended Market Index Fund | 185,669 | 30 Mar 2024 | 0.75% | 8,655,888 |
USAA Mutual Fund Tr-Science & Technology Fund | 138,801 | 29 Apr 2024 | 0.56% | 6,470,902 |
Janus Henderson Global Life Sciences Fund | 126,306 | 30 Mar 2024 | 0.51% | 5,888,385 |
Fidelity Small Cap Index Fund | 93,832 | 29 Apr 2024 | 0.38% | 4,374,447 |
iShares Biotechnology ETF | 89,217 | 30 May 2024 | 0.36% | 4,159,296 |